The role of miR-125b-mitochondria-caspase-3 pathway in doxorubicin resistance and therapy in human breast cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of miR-125b-mitochondria-caspase-3 pathway in doxorubicin resistance and therapy in human breast cancer
Authors
Keywords
Breast cancer, miR-125b, Doxorubicin, Mcl-1, Apoptosis, MMP
Journal
TUMOR BIOLOGY
Volume 36, Issue 9, Pages 7185-7194
Publisher
Springer Nature
Online
2015-04-17
DOI
10.1007/s13277-015-3438-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR-135a inhibition protects A549 cells from LPS-induced apoptosis by targeting Bcl-2
- (2014) Jing Zhao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Differential drug resistance acquisition to doxorubicin and paclitaxel in breast cancer cells
- (2014) Feifei Xu et al. Cancer Cell International
- Sensitization of U937 leukemia cells to doxorubicin by the MG132 proteasome inhibitor induces an increase in apoptosis by suppressing NF-kappa B and mitochondrial membrane potential loss
- (2014) Pablo Ortiz-Lazareno et al. Cancer Cell International
- MiR-125b inhibits cell biological progression of Ewing's sarcoma by suppressing the PI3K/Akt signalling pathway
- (2014) J. Li et al. CELL PROLIFERATION
- Prognostic Marker MicroRNA-125b Inhibits Tumorigenic Properties of Hepatocellular Carcinoma Cells Via Suppressing Tumorigenic Molecule eIF5A2
- (2014) Felice H. Tsang et al. DIGESTIVE DISEASES AND SCIENCES
- miR-125bcan enhance skin tumor initiation and promote malignant progression by repressing differentiation and prolonging cell survival
- (2014) Liang Zhang et al. GENES & DEVELOPMENT
- BAG3 upregulates Mcl-1 through downregulation of miR-29b to induce anticancer drug resistance in ovarian cancer
- (2014) Asuka Sugio et al. GYNECOLOGIC ONCOLOGY
- Nucleotropic doxorubicin nanoparticles decrease cancer cell viability, destroy mitochondria, induce autophagy and enhance tumour necrosis
- (2014) Anna M. Friedhuber et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- MiR-363 sensitizes cisplatin-induced apoptosis targeting in Mcl-1 in breast cancer
- (2014) Ruiguang Zhang et al. MEDICAL ONCOLOGY
- PI3K and Bcl-2 Inhibition Primes Glioblastoma Cells to Apoptosis through Downregulation of Mcl-1 and Phospho-BAD
- (2014) Fresia Pareja et al. MOLECULAR CANCER RESEARCH
- Synergistic Nanoparticulate Drug Combination Overcomes Multidrug Resistance, Increases Efficacy, and Reduces Cardiotoxicity in a Nonimmunocompromised Breast Tumor Model
- (2014) Adam J. Shuhendler et al. MOLECULAR PHARMACEUTICS
- Protective Effect of Boerhaavia diffusa L. against Mitochondrial Dysfunction in Angiotensin II Induced Hypertrophy in H9c2 Cardiomyoblast Cells
- (2014) Ayyappan Prathapan et al. PLoS One
- The ratio of Mcl-1 and Noxa determines ABT737 resistance in squamous cell carcinoma of the skin
- (2014) P Geserick et al. Cell Death & Disease
- The Mitochondrial Permeability Transition Pore and Cancer: Molecular Mechanisms Involved in Cell Death
- (2014) Massimo Bonora et al. Frontiers in Oncology
- MiR-106a targets Mcl-1 to suppress cisplatin resistance of ovarian cancer A2780 cells
- (2013) Yu-mei Rao et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- miR-125b Acts as a Tumor Suppressor in Breast Tumorigenesis via Its Novel Direct Targets ENPEP, CK2-α, CCNJ, and MEGF9
- (2013) Andrea Feliciano et al. PLoS One
- Increased Expression of P-Glycoprotein and Doxorubicin Chemoresistance of Metastatic Breast Cancer Is Regulated by miR-298
- (2012) Lili Bao et al. AMERICAN JOURNAL OF PATHOLOGY
- MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6R
- (2012) J Gong et al. ONCOGENE
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012
- (2011) L Galluzzi et al. CELL DEATH AND DIFFERENTIATION
- Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1
- (2011) Benjamin Boyerinas et al. INTERNATIONAL JOURNAL OF CANCER
- Reversed urban–rural differences in breast cancer mortality (China, 2002–2008)
- (2010) Min He et al. BREAST CANCER RESEARCH AND TREATMENT
- MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3
- (2010) Li Huang et al. INTERNATIONAL JOURNAL OF CANCER
- MiR-125b targets BCL3 and suppresses ovarian cancer proliferation
- (2010) Yi Guan et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting mitochondria for cancer therapy
- (2010) Simone Fulda et al. NATURE REVIEWS DRUG DISCOVERY
- MicroRNA control of signal transduction
- (2010) Masafumi Inui et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Mitochondria and cell death: outer membrane permeabilization and beyond
- (2010) Stephen W. G. Tait et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- MicroRNAs in Cancer
- (2008) Yong Sun Lee et al. Annual Review of Pathology-Mechanisms of Disease
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search